Drug Repurposing for Rare Diseases: A Role for Academia
Background: The European Commission highlights in its Pharmaceutical Strategy the role of academic researchers in drug repurposing, especially in the development of orphan medicinal products (OMPs). This study summarizes the contribution of academia over the last 5 years to registered repurposed OMP...
Saved in:
Main Authors: | Sibren van den Berg (Author), Saco de Visser (Author), Hubert G.M. Leufkens (Author), Carla E.M. Hollak (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Access to medicines for rare diseases: A European regulatory roadmap for academia
by: Noa Rosenberg, et al.
Published: (2023) -
Rare essentials: drugs for rare diseases as essential medicines
by: Pieter Stolk, et al.
Published: (2006) -
Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects
by: Yasmin Polak, et al.
Published: (2023) -
De val van Sora
by: van den Berg, E.
Published: (1939) -
De val van Sora
by: van den Berg, E.
Published: (1939)